Sutro Biopharma Reports Third Quarter 2026 Financial Results and Business Highlights
results
View All ->Sutro Biopharma Reports Third Quarter 2026 Financial Results and Business Highlights
– STRO-004, TF-targeting ADC, Phase 1 STRIVE-01 study advancing; next clinical update and initiation of expansion cohorts planned first half of 2027 – – STRO-006, ITGB6-targeting ADC, enters clinic with first patient dosed; initial update expected second half of 2027 – – STRO-227, Sutro’s PTK7-targeting dual-payload ADC, advancing toward clinical development early 2027 – – Astellas dosed first patient in second dual-payload iADC program, triggering milestone payment to Sutro – – Strong balance s
Standard Lithium Reports Third Quarter 2026 Results
Announced and Filed Positive Preliminary Economic Assessment (“PEA”) for the High-Grade 70,000 Tonnes Per Year Franklin Project Completed South West Arkansas Project (“SWA Project”) Customer Offtake Process through Binding Agreements with LG Energy Solution and Trafigura Advanced SWA Project Financing Process, the Key Remaining Workstream Prior to a Final Investment Decision (“FID”) Expect to Take FID by Q1 2027 Followed Promptly by Construction VANCOUVER, British Columbia, Nov. 12, 2026 (GLOBE
newsMartinrea International Inc. Reports Third Quarter Results and Declares Dividend
TORONTO, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Martinrea International Inc. (TSX : MRE), a diversified and global automotive supplier engaged in the design, development and manufacturing of highly engineered, value-added Lightweight Structures and Propulsion Systems, today announced the release of its financial results for the third quarter ended September 30, 2026, and declared a quarterly cash dividend of $0.05 per share. THIRD-QUARTER HIGHLIGHTS Total sales of $1,181.9 million, production sales o
quarter
View All ->Sutro Biopharma Reports Third Quarter 2026 Financial Results and Business Highlights
– STRO-004, TF-targeting ADC, Phase 1 STRIVE-01 study advancing; next clinical update and initiation of expansion cohorts planned first half of 2027 – – STRO-006, ITGB6-targeting ADC, enters clinic with first patient dosed; initial update expected second half of 2027 – – STRO-227, Sutro’s PTK7-targeting dual-payload ADC, advancing toward clinical development early 2027 – – Astellas dosed first patient in second dual-payload iADC program, triggering milestone payment to Sutro – – Strong balance s
Standard Lithium Reports Third Quarter 2026 Results
Announced and Filed Positive Preliminary Economic Assessment (“PEA”) for the High-Grade 70,000 Tonnes Per Year Franklin Project Completed South West Arkansas Project (“SWA Project”) Customer Offtake Process through Binding Agreements with LG Energy Solution and Trafigura Advanced SWA Project Financing Process, the Key Remaining Workstream Prior to a Final Investment Decision (“FID”) Expect to Take FID by Q1 2027 Followed Promptly by Construction VANCOUVER, British Columbia, Nov. 12, 2026 (GLOBE
newsMartinrea International Inc. Reports Third Quarter Results and Declares Dividend
TORONTO, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Martinrea International Inc. (TSX : MRE), a diversified and global automotive supplier engaged in the design, development and manufacturing of highly engineered, value-added Lightweight Structures and Propulsion Systems, today announced the release of its financial results for the third quarter ended September 30, 2026, and declared a quarterly cash dividend of $0.05 per share. THIRD-QUARTER HIGHLIGHTS Total sales of $1,181.9 million, production sales o
third
View All ->Sutro Biopharma Reports Third Quarter 2026 Financial Results and Business Highlights
– STRO-004, TF-targeting ADC, Phase 1 STRIVE-01 study advancing; next clinical update and initiation of expansion cohorts planned first half of 2027 – – STRO-006, ITGB6-targeting ADC, enters clinic with first patient dosed; initial update expected second half of 2027 – – STRO-227, Sutro’s PTK7-targeting dual-payload ADC, advancing toward clinical development early 2027 – – Astellas dosed first patient in second dual-payload iADC program, triggering milestone payment to Sutro – – Strong balance s
Standard Lithium Reports Third Quarter 2026 Results
Announced and Filed Positive Preliminary Economic Assessment (“PEA”) for the High-Grade 70,000 Tonnes Per Year Franklin Project Completed South West Arkansas Project (“SWA Project”) Customer Offtake Process through Binding Agreements with LG Energy Solution and Trafigura Advanced SWA Project Financing Process, the Key Remaining Workstream Prior to a Final Investment Decision (“FID”) Expect to Take FID by Q1 2027 Followed Promptly by Construction VANCOUVER, British Columbia, Nov. 12, 2026 (GLOBE
newsMartinrea International Inc. Reports Third Quarter Results and Declares Dividend
TORONTO, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Martinrea International Inc. (TSX : MRE), a diversified and global automotive supplier engaged in the design, development and manufacturing of highly engineered, value-added Lightweight Structures and Propulsion Systems, today announced the release of its financial results for the third quarter ended September 30, 2026, and declared a quarterly cash dividend of $0.05 per share. THIRD-QUARTER HIGHLIGHTS Total sales of $1,181.9 million, production sales o
reports
View All ->Sutro Biopharma Reports Third Quarter 2026 Financial Results and Business Highlights
– STRO-004, TF-targeting ADC, Phase 1 STRIVE-01 study advancing; next clinical update and initiation of expansion cohorts planned first half of 2027 – – STRO-006, ITGB6-targeting ADC, enters clinic with first patient dosed; initial update expected second half of 2027 – – STRO-227, Sutro’s PTK7-targeting dual-payload ADC, advancing toward clinical development early 2027 – – Astellas dosed first patient in second dual-payload iADC program, triggering milestone payment to Sutro – – Strong balance s
Standard Lithium Reports Third Quarter 2026 Results
Announced and Filed Positive Preliminary Economic Assessment (“PEA”) for the High-Grade 70,000 Tonnes Per Year Franklin Project Completed South West Arkansas Project (“SWA Project”) Customer Offtake Process through Binding Agreements with LG Energy Solution and Trafigura Advanced SWA Project Financing Process, the Key Remaining Workstream Prior to a Final Investment Decision (“FID”) Expect to Take FID by Q1 2027 Followed Promptly by Construction VANCOUVER, British Columbia, Nov. 12, 2026 (GLOBE
newsMartinrea International Inc. Reports Third Quarter Results and Declares Dividend
TORONTO, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Martinrea International Inc. (TSX : MRE), a diversified and global automotive supplier engaged in the design, development and manufacturing of highly engineered, value-added Lightweight Structures and Propulsion Systems, today announced the release of its financial results for the third quarter ended September 30, 2026, and declared a quarterly cash dividend of $0.05 per share. THIRD-QUARTER HIGHLIGHTS Total sales of $1,181.9 million, production sales o
financial
View All ->Sutro Biopharma Reports Third Quarter 2026 Financial Results and Business Highlights
– STRO-004, TF-targeting ADC, Phase 1 STRIVE-01 study advancing; next clinical update and initiation of expansion cohorts planned first half of 2027 – – STRO-006, ITGB6-targeting ADC, enters clinic with first patient dosed; initial update expected second half of 2027 – – STRO-227, Sutro’s PTK7-targeting dual-payload ADC, advancing toward clinical development early 2027 – – Astellas dosed first patient in second dual-payload iADC program, triggering milestone payment to Sutro – – Strong balance s
Aeluma Announces First Quarter Fiscal 2027 Financial Results
Continued Progress in Technology Readiness for AI Datacom Market Executed Purchase Agreement With Aixtron for MOCVD Capacity Expansion and Large-Diameter Wafer Manufacturing GOLETA, Calif., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Aeluma, Inc. (NASDAQ: ALMU) (“Aeluma” or the “Company”), a semiconductor company specializing in high-performance, scalable technologies for AI, mobile and consumer, defense and aerospace, and quantum, today reported financial results for its first quarter of fiscal 2027 ende
newsBattalion Oil Corporation Announces Third Quarter 2026 Financial and Operating Results
HOUSTON, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Battalion Oil Corporation (NYSE American: BATL, “Battalion” or the “Company”) today announced financial and operating results for the third quarter of 2026. Key Q3 2026 Highlights Generated third quarter 2026 sales volumes of 11,359 barrels of oil equivalent per day (“Boe/d”) (~43% oil, 69% liquids) Ended the quarter with $92.1 million of cash and cash equivalents and net debt (term loan indebtedness less cash and cash equivalents) of $70.4 million, dow
Magazine Focus
The New Growth Playbook: Building Businesses for Sustainable Expansion
Growth is being redefined. Expanding revenue remains important, but businesses are placing greater emphasis on profitability, cash discipline, operational efficiency, customer retention and resilience. This edition explores the changing growth playbook and the foundations required for sustainable expansion. From technology and process design to capital allocation and market reach, it examines how businesses can pursue ambition without allowing complexity, costs or uncontrolled expansion to weaken the enterprise.
For years, growth was often discussed primarily in terms of size, speed and market share. The conversation is becoming more balanced. Strong businesses also need healthy economics, efficient operations and the ability to withstand uncertainty. This edition looks at growth through that wider lens and considers how organizations can expand with greater discipline, clarity and long-term purpose in practice.
The day in focus. Delivered to your inbox.
A concise daily briefing of key stories, insights and developments, selected by our editorial team.
By subscribing, you agree to our Privacy Policy. Unsubscribe at any time.